| 1 |
33026315 | CYP3A5 genetic variants and their associations with carbamazepine and valproic acid response in Malaysian epileptic patients. | 2021 Jan |
6 |
| 2 |
33756436 | Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis. | 2021 Jul |
3 |
| 3 |
34648292 | Unraveling the Structural Basis of Selective Inhibition of Human Cytochrome P450 3A5. | 2021 Nov 10 |
8 |
| 4 |
32029960 | Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on dose-adjusted plasma levels of carbamazepine in epileptic patients in South Indian population. | 2019 Nov-Dec |
8 |
| 5 |
30045320 | Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients. | 2018 Jul |
1 |
| 6 |
29441960 | Carbamazepine 10,11-epoxidation in human liver microsomes: influence of the CYP3A5*3 polymorphism. | 2017 Dec 1 |
2 |
| 7 |
26421491 | Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. | 2015 Nov |
4 |
| 8 |
24406279 | Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response. | 2014 |
1 |
| 9 |
25495409 | Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy. | 2014 |
1 |
| 10 |
23252947 | Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. | 2013 Jan |
1 |
| 11 |
24210059 | Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients. | 2013 |
19 |
| 12 |
19744012 | Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients. | 2009 Oct |
9 |
| 13 |
16678552 | Effect of CYP3A5*3 on carbamazepine pharmacokinetics in Japanese patients with epilepsy. | 2006 May |
1 |
| 14 |
15383492 | Evidence of significant contribution from CYP3A5 to hepatic drug metabolism. | 2004 Dec |
1 |
| 15 |
12673034 | Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. | 2003 Apr |
2 |